Skip to main content
Log in

Absence of interaction between tenoxicam and warfarin

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The influence of tenoxicam on plasma warfarin concentrations and on its anticoagulant effect has been studied in healthy volunteers. Tenoxicam did not alter the plasma warfarin concentration versus time profile. Treatment with it for 14 days had no effect on the average dose of warfarin required to maintain the prothrombin time within a specified range. The coumarin dose index, an indicator of warfarin sensitivity, remained unchanged during tenoxicam administration. The results demonstrate the lack of a clinically relevant effect of tenoxicam on warfarin-induced anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • De Vries JX, Harenberg J, Walter E, Zimmermann R, Simon M (1982) Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography. J Chromatogr 231: 83–92

    Google Scholar 

  • Gonzalez JP, Todd PA (1987) Tenoxicam — a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 34: 298–310

    Google Scholar 

  • Gugler R (1979) Arzneimittelwechselwirkungen in der Therapie mit Cumarin-Derivaten. Internist 20: 238–244

    Google Scholar 

  • Koch-Weser J, Sellers EM (1971a) Drug interactions with coumarin anticoagulants (First of two parts). N Engl J Med 285: 487–498

    Google Scholar 

  • Koch-Weser J, Sellers EM (1971b) Drug interactions with coumarin anticoagulants (Second of two parts). N Engl J Med 285: 547–558

    Google Scholar 

  • Lechner K (1982) Blutgerinnungsstörungen — Laboratoriumsdiagnostik hämatologischer Erkrankungen. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Lewis RJ, Trager WF, Chan KK, Breckenridge A, Orme M, Roland M, Schary W (1974) Warfarin — stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest 53: 1607–1617

    Google Scholar 

  • Penner JA, Abbrecht PH (1975) Lack of interaction between ibuprofen and warfarin. Curr Ther Res 18: 862–871

    Google Scholar 

  • Pickup ME, Lowe JR, Galloway DB (1981) Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatography. J Chromatogr 225: 493–497

    Google Scholar 

  • Rüst O, Biland L, Thilo D, Nyman D, Duckert F (1975) Prüfung des Antirheumatikums Tolmetin auf Interaktionen mit oralen Antikoagulantien. Schweiz Med Wochenschr 105: 752–753

    Google Scholar 

  • Wiseman EH, Lombardino JG (1981) Oxicams — a novel family of non-steroidal anti-inflammatory drugs. Eur J Rheumatol Inflamm 4: 280–297

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eichler, HG., Jung, M., Kyrle, P.A. et al. Absence of interaction between tenoxicam and warfarin. Eur J Clin Pharmacol 42, 227–229 (1992). https://doi.org/10.1007/BF00278491

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00278491

Key words

Navigation